Trk 13: CER-Glob Health Econ [
clear filter]
10:45am EDT
#139: Measuring the Impact and Influence of Patient Input on Regulatory and Health Technology Assessment Decision Making: What Are the Key Considerations?
Chair
Director, Centre for Innovation in Regulatory Science (CIRS), United Kingdom
Neil McAuslane is Director of the Centre for Innovation in Regulatory Science (CIRS, previously CMR International) and works in the area of regulatory and HTA strategy and R&D performance. Prior to joining CMR International in 1988, Neil completed his PhD degree in Clinical Pharmacology...
Read More →
Speakers
Associate Director for Strategic Initiatives, CDER, FDA, United States
Dr. Mullin is Associate Center Director for Strategic Initiatives. She leads efforts including Patient-Focused Drug Development, Rare Disease Cures Accelerator, and CDER’s International Program. She leads the FDA delegation to ICH and currently chairs the ICH Management Committee...
Read More →
Head of Public Involvement, Public Involvement Programme, National Institute For Health and Care Excellence (NICE)
Victoria Thomas has run the Public Involvement Programme at NICE since 2009, and has been with the Programme since 2001. Following a degree in Art History, Victoria has worked exclusively in the public and voluntary sector, specialising in healthcare quality improvement activities...
Read More →
President and Chief Executive Officer, Canadian Organization For Rare Disorders (CORD)
Durhane Wong-Rieger, PhD, is President, Institute for Optimizing Health Outcomes; President; Canadian Organization for Rare Disorders; Chair, Consumer Advocare Network; Past-Chair, International Alliance of Patient Organizations; Co-Chair, HTAi Patient / Citizen Involvement IG; Board...
Read More →
Monday June 27, 2016 10:45am - 12:00pm EDT
105AB
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
10:30am EDT
#224: Identifying Patient-Centered Outcomes for Use in Observational Research: Why and How
Speakers EB
Director, Technology Assessment Program, Agency For Healthcare Research and Quality (AHRQ)
Dr. Berliner is the Director of the Technology Assessment Program at the Agency for Healthcare Research and Quality (AHRQ). The Technology Assessment Program provides technology assessments to the Centers for Medicare & Medicaid Services (CMS) to inform Medicare coverage decisions...
Read More →
Chief Executive Officer, Better Outcomes
Dr. Richard Gliklich is the CEO of Better Outcomes Corporation. He was founder and CEO of Outcome Sciences, a health information and services company. He led the company from inception through its acquisition by Quintiles. A graduate of Yale University and Harvard Medical School and...
Read More →
Tuesday June 28, 2016 10:30am - 11:30am EDT
201A
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
2:00pm EDT
#247: Fit for Purpose and Modern Validity Theory in PROs
Chair
President, Vector Psychometric Group, LLC
R.J. Wirth is President and managing partner at VPG. He trained in the L. L. Thurstone Psychometric Lab, receiving his PhD in Quantitative Psychology from the University of North Carolina – Chapel Hill. His research focuses on modern psychometrics with an emphasis on measurement...
Read More →
Speakers ME
Managing Partner, Vector Psychometric Group, LLC
Michael C. Edwards is a managing partner at VPG. He earned his PhD in Quantitative Psychology from the University of North Carolina – Chapel Hill. His research is generally focused on modern psychometrics with specific emphases on item response theory, factor analysis, and computerized...
Read More →
Psychometrician, National Board of Medical Examiners
As psychometrician at the National Board of Medical Examiners, Jonathan shoulders operational responsibility for high-stakes medical exams and leads exam-related research. Prior to NBME, he worked at AICPA and also evaluated tests to support research on human subjects with impaired...
Read More →
Principal, Scientific and Regulatory Consulting, Aspen Consulting, LLC
Dr. Slagle is a scientific and regulatory expert, providing advice on patient centered drug development to drug product developers. Formerly with the US FDA Clinical Outcome Assessment (COA) Staff, her experience includes over 15 years of policy analysis and outcomes research, including...
Read More →
Tuesday June 28, 2016 2:00pm - 3:15pm EDT
105AB
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA